EQS-News: Marinomed Biotech AG / Key word: Quarter Results
Marinomed Biotech AG reports best first quarter in company history
23.05.2023 / 07:45 CET/CEST
The issuer is solely. | May 23, 2023
EQS-News: Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023 finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.
EQS-News: Marinomed Biotech AG / Key word(s): Annual ResultsMarinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023 19.04.2023 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement. Marinomed Biotech AG with Carragelose record sales in 2022and pos.
EQS-News: Marinomed Biotech AG / Key word(s): Study resultsMarinomed Biotech AG publishes clinical data on the effectiveness of its Carragelose nasal spray in the treatment of hay fever 12.04.2023 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement.Marinomed Biotech AG publishes c.